Gibson Research Consultancy
Gibson Research Consultancy (GRC Health) is a Leeds-based, founder-owned specialist firm providing multilingual patient-centred research services — including COA linguistic validation, usability testing, and product labelling — to pharmaceutical, biotech, and medical device clients across 190+ countries and 250+ languages.
- Company typePrivate
- Founded2008
- HeadquartersLeeds, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Gibson Research Consultancy does
Gibson Research Consultancy (GRC), doing business as GRC Health, is a privately held, founder-owned specialist health research and communication services firm headquartered in Leeds, United Kingdom, with branch offices in Ávila, Spain and Guatemala City. Founded in 2008 by Mark Gibson, the company delivers multilingual patient-centred research services — including Clinical Outcome Assessment (COA and eCOA) linguistic validation, usability testing, information design and testing, product labelling, MedTech human-factor studies, brand name support, pharmacovigilance, and patient voice research — to pharmaceutical, biotech, medical device, CRO, and consumer health clients across more than 190 countries and 250 languages.
The company's operating model is built on a global network of over 17,000 expert collaborators that enables access to rare languages (Krio, Dholuo, Twi), creoles, minority languages, and indigenous languages such as Te Reo Māori and K'iche'. Its core technical assets include a proprietary methodology for COA/eCOA development and an internal Cognitive Burden Simulator used to analyse the cognitive demands of clinical outcome assessments. GRC has completed over 9,000 individual in-country studies and conducts more than 20,000 patient interviews annually.
GRC monetises through quote-based project fees under a professional services model, distributing work via direct enterprise sales to pharma/biotech/MedTech clients and through channel partnerships with CROs and language service providers. The firm is bootstrapped with no disclosed external funding and is organised as a UK private limited company under the laws of England and Wales (Companies House registration 12210212). Marketing is content-led via a 200+ article Knowledge Centre distributed across LinkedIn, X, Instagram, TikTok, YouTube, WordPress, Medium, and Substack.
Gibson Research Consultancy firmographics
Firmographics- Name
- Gibson Research Consultancy
- Legal name
- Gibson Research Consultancy
- Website
- https://grc-health.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Gibson Research Consultancy (GRC Health) is a Leeds-based, founder-owned specialist firm providing multilingual patient-centred research services — including COA linguistic validation, usability testing, and product labelling — to pharmaceutical, biotech, and medical device clients across 190+ countries and 250+ languages.
- Ownership category
- akta.pro rank
Gibson Research Consultancy industry classification
Industry- Product category
- Healthcare Research Services
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Clinical Trial Analytics, Risk-Based Monitoring (RBM) & Quality Management (HLACAOAI), Real-World Evidence (RWE) & HEOR for Development (HLAIALAI), Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)
Keywords
Where Gibson Research Consultancy is headquartered
LocationHeadquarters
- HQ city
- Leeds
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Gibson Research Consultancy business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Clinical Research Services: Project-based professional services for pharmaceutical, biotech, and medical device companies including linguistic validation, usability testing, patient insights research, and regulatory documentation services
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Gibson Research Consultancy product offering
Product offeringCore offering
Gibson Research Consultancy provides multilingual patient-centred research services to pharmaceutical, biotech and medical device companies. Its core offerings are project-based professional services including linguistic validation of Clinical Outcome Assessments (COA/eCOA), usability and human-factor testing of medical apps and devices, regulatory product labelling reviews, patient insights and qualitative research, health promotion research, brand name screening, and pharmacovigilance communication support, delivered through a curated network of 17,000+ in-country experts across 190+ countries and 250+ languages.
Product overview
Gibson Research Consultancy (GRC) operates as a health research and communication services company offering a portfolio of 10 integrated service lines focused on patient-centred research. The core offering centers on Real-World Experience (RWE) and Clinical Outcome Assessments (COA) linguistic validation and development, supported by complementary services including Usability Testing, Information Design and Testing, and Research for Health Promotion. These primary services are complemented by The Patient Voice (qualitative patient engagement research), Product Labelling (regulatory reviews), MedTech (medical device services), Consumer Health, Brand Name Support, and Pharmacovigilance. All services leverage a global network spanning 190+ territories, 250+ languages, and 17,000+ expert collaborators. The company was founded in 2008 and has completed over 9,000 projects to date.
Differentiator
Problem solved
Functional benefit
Products and services
- Real-World Experience (RWE) and Clinical Outcome Assessments (COA) Linguistic validation and development services for Clinical Outcome Assessments (COAs) and electronic COAs (eCOAs), including item development, concept elicitation, cognitive debriefing, and usability testing. Built for pharmaceutical and biotech sponsors that need patient-facing clinical outcome instruments validated across 250+ languages and 190+ countries.
- Usability Testing Human-factor and usability testing of healthcare IT applications, including eCOA instruments, electronic patient diaries, medical apps, health content websites, and medical device instructions for use, delivered on a multilingual, international basis. Targeted at pharma, biotech, and MedTech manufacturers needing validated usability evidence for regulatory submissions.
- Information Design and Testing Writing, designing, and testing patient-oriented materials including lay summaries, patient information sheets, consent forms, package leaflets, and instructions for use, including readability user testing in EU languages and global labelling for pharma/biotech and MedTech products. Designed for sponsors that need regulatory-compliant patient-facing documents validated by target populations.
- Research for Health Promotion Health promotion and disease prevention campaign support, including messaging development, community engagement infrastructure, usability testing of health software, design of public health materials, linguistic and cultural communication strategies, and outcomes research for communities. Built for health organisations, NGOs and public-sector bodies running prevention campaigns.
- The Patient Voice Qualitative research services engaging patient perspectives across drug development, clinical phases, and post-approval Risk Management Plans, including Global Real-World Evidence research, Patient Insights research, Patient Voice research, and Key Opinion Leader research. Designed for pharma and biotech sponsors needing qualitative patient evidence throughout the product lifecycle.
- Product Labelling Full regulatory reviews of product labelling globally for investigational medicinal products, post-marketed pharmaceutical/biotech products, medical devices, food and beverage products, and cosmetics. Built for sponsors that need consistent, regulator-ready labelling across multiple markets.
- MedTech Medical and surgical device services covering global labelling, regulatory affairs, human factor testing of home-use devices, device software and apps testing, and digiceuticals content creation and usability testing. Built for MedTech manufacturers needing integrated global launch readiness.
- Consumer Health Patient communication and patient-centred research services with international scope, including development and testing of patient education materials, patient insights research, healthcare professional perspective research, and Key Opinion Leader research. Designed for consumer health and OTC product companies.
- Brand Name Support Brand name testing and screening services for new medicines, including review for similarities and confusion, candidate name implications analysis, pronunciation testing, and market research with health professionals and patients, aligned with the FDA DMEPA review process. Built for pharma and biotech sponsors preparing for regulatory brand name submission.
- Pharmacovigilance Design and execution support for Risk Management and Risk Minimisation plans as part of wider pharmacovigilance measures, including patient education materials development, special communication programmes for healthcare professionals and patients, and user evaluation studies for communication plan effectiveness. Built for pharma sponsors needing post-approval risk management evidence.
Quantifiable outcome
- Over 9,000 individual in-country studies completed covering 250+ languages
- +2 more outcomes
Companies that use Gibson Research Consultancy
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles5 records
Gibson Research Consultancy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Gibson Research Consultancy partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Coquelle ConsultingcoreGRC Health and Coquelle Consulting announced strategic partnership to deliver end-to-end patient-centred evidence in global clinical development. The partnership combines GRC's multilingual patient research capabilities with Coquelle Consulting's expertise to provide comprehensive patient-centred evidence solutions.
- Language Service ProviderscoreGRC partners with trusted Language Service Providers for translation and localisation services, typically doing this in-house but partnering with LSPs when needed. LSPs also act as clients referring specialised linguistic validation and patient testing projects to GRC.
- Marketing and Branding CompaniesminorPartnering with established marketing and branding companies to provide full brand checking and screening services for pharmaceutical brand names.
Scale indicators6 records
Recent moves5 records
Expansion highlights5 records
Gibson Research Consultancy competitors and assessment
Company assessmentEmerging players
- Clinical Ink: Clinical Ink focuses on eCOA and clinical technology solutions, with overlap in the eCOA usability testing and instrument validation workflows where GRC operates. Useful as a more technology-centric peer in the eCOA ecosystem.
- Pro-ficiency: Pro-ficiency provides clinical trial simulation, training, and patient engagement tools, with related focus on real-world evidence and protocol usability. Adjacent to GRC's patient-insight and clinical-phase research offerings.
- Moderation Solutions: Moderation Solutions specialises in linguistic validation and patient interview moderation for clinical outcome assessments. A more boutique, niche peer with a similar patient-centred research focus.
Broad incumbents
- ICON plc (formerly Mapi Group / Mapi Research Trust): ICON acquired Mapi, the long-standing leader in COA linguistic validation and eCOA services. Directly comparable to GRC's core COA/eCOA offering, but operates as part of ICON's global full-service CRO platform serving large pharma sponsors.
- Parexel International: Parexel is a major global CRO delivering clinical development services to biopharma, with related capabilities in patient experience, usability, and global labelling. Comparable as a broader-scale incumbent offering overlapping patient-research services.
- IQVIA: IQVIA is the largest global CRO offering comprehensive clinical trial services including linguistic validation, patient insights, and real-world evidence. Comparable as a buyer or competitor in patient-centred research and COA work.
Direct peers
- RWS Group: RWS provides specialised language and content solutions to life sciences clients, including linguistic validation of COAs, regulatory documentation, and clinical trial content. A direct competitor with broader language-services scale.
- Lionbridge Life Sciences: Lionbridge provides translation and linguistic validation services for clinical trials and COAs across many languages. Competes with GRC in linguistic validation, patient-facing materials, and global pharma/biotech language support.
- TransPerfect Life Sciences: TransPerfect's Life Sciences division delivers linguistic validation, COA translation, and patient-facing documentation testing for pharma/biotech. Directly competes with GRC in multilingual COA services, with a larger corporate footprint.
Others
- Critical Path Institute: C-Path develops and qualifies clinical outcome assessments and supports patient-focused drug development consortia. Not a direct competitor but an ecosystem peer in the COA/eCOA development community where GRC's linguistic validation expertise is consumed.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Gibson Research Consultancy social profiles
Digital presenceGibson Research Consultancy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Gibson Research Consultancy leadership team
Management profileNumber of profiles
Profiles2 records
Gibson Research Consultancy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Gibson Research Consultancy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Gibson Research Consultancy
What does Gibson Research Consultancy do?
Gibson Research Consultancy provides multilingual patient-centred research services to pharmaceutical, biotech and medical device companies. Its core offerings are project-based professional services including linguistic validation of Clinical Outcome Assessments (COA/eCOA), usability and human-factor testing of medical apps and devices, regulatory product labelling reviews, patient insights and qualitative research, health promotion research, brand name screening, and pharmacovigilance communication support, delivered through a curated network of 17,000+ in-country experts across 190+ countries and 250+ languages.
Is Gibson Research Consultancy a public or private company?
Gibson Research Consultancy is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Gibson Research Consultancy founded?
Gibson Research Consultancy was founded in 2008. It employs 11 to 50 people.
Where is Gibson Research Consultancy based?
Gibson Research Consultancy is headquartered in Leeds, United Kingdom, in the Europe region.
How does Gibson Research Consultancy make money?
One revenue line is on record: clinical Research Services.
Who are Gibson Research Consultancy's main competitors?
Emerging players on record are Clinical Ink, Pro-ficiency and Moderation Solutions. Broad incumbents are ICON plc (formerly Mapi Group / Mapi Research Trust), Parexel International and IQVIA. Direct peers are RWS Group, Lionbridge Life Sciences and TransPerfect Life Sciences. Critical Path Institute is listed as an others.
Does Gibson Research Consultancy have an API?
No public API is recorded for Gibson Research Consultancy.
What industry is Gibson Research Consultancy in?
Gibson Research Consultancy's product category is Healthcare Research Services. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAI, Clinical Trial Analytics, Risk-Based Monitoring (RBM) & Quality Management. Its NAICS code is 5417 and its SIC code is 8731.